This content is from:Premium D.E. Shaw Has Unusually Close Ties to This Tech Company A close look at D.E. Shaw’s business arrangements with a tech company that recently filed to go public. ByStephen Taub January 21, 2020
This content is from:www.yabo88.com JPMorgan Is Hunting for Properties in a Sector Poised for Post-Covid Growth Demand for lab space will probably rise over the long term due to the Covid-19 pandemic, says Anton Pil, global head of alternatives at J.P. Morgan Asset Management. By克里斯汀Idzelis November 24, 2020
This content is from:365亚博 This Hedge Fund Is ‘Reasonably Confident’ a Covid-19 Vaccine Will Be Approved This Year MKP Capital has also calculated the odds of the FDA approving a vaccine before the U.S. presidential election. By克里斯汀Idzelis September 10, 2020
This content is from:Premium Short Sellers Won in Mallinckrodt Mess, but Some Hedgies Held On The specialty pharmaceutical company settled opioid lawsuit and is considering restructuring. ByMichelle Celarier September 10, 2019
This content is from:Premium This Hong Kong Hedge Fund With Tiger Management Ties Crushed It in the Second Quarter Tybourne’s Covid-19 strategy paid off. ByStephen Taub July 30, 2020
This content is from:365亚博 The Morning Brief: President Trump Puts Drug Stocks in the Crosshairs Biotech funds and drug companies fell following reports that President Trump plans to take action on lowering drug prices. ByStephen Taub June 16, 2017
